IndiaTickerLatest filing: Vanta Bioscience Ltd - 540729 - Audited Standalone And Consolidated Financial Results For The Half Year And Financial Year Ended March 31, 2026
ObservedCompany dossier
Vanta Bioscience
BSE:VANTABIO · ISIN INE695X01011
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Vanta Bioscience
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 72.81% and public 27.19% as of 31 Mar 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Vanta Bioscience Ltd - 540729 - Audited Standalone And Consolidated Financial Results For The Half Year And Financial Year Ended March 31, 2026
BSE · financial results
Observed
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 30.05.2026
BSE · exchange filing
Observed
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Results For The Half Year And Financial Year Ended March 31, 2026 - Board Meeting To Be Held On May 30, 2026
BSE · financial results
Observed
Source filing Vanta Bioscience Ltd - 540729 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →31 Mar 2026
- Promoter group
- 72.81%
- Public
- 27.19%
- Employee trust
- N/A
Observed BSE shareholding XBRL